Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM
Mar 2, 2026 01:10AM
Feb 20, 2026 02:00AM
Feb 20, 2026 02:00AM
Feb 20, 2026 01:05AM FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
Feb 16, 2026 05:31PM
Feb 16, 2026 01:00AM
Feb 7, 2026 03:40PM
Dec 22, 2025 01:01AM
Dec 22, 2025 01:00AM
Dec 16, 2025 08:30AM
Dec 8, 2025 04:30PM Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
Nov 10, 2025 01:10AM
Nov 3, 2025 09:00AM
Nov 3, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 20, 2025 01:05AM
Oct 20, 2025 01:01AM
Oct 20, 2025 01:00AM FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis
Oct 16, 2025 11:49AM
Oct 16, 2025 11:45AM
Oct 13, 2025 09:00AM
Oct 13, 2025 01:05AM
Oct 2, 2025 06:30PM
Oct 2, 2025 06:30PM
Sep 24, 2025 02:30AM Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025
Sep 18, 2025 10:00AM
Sep 5, 2025 01:00AM
Aug 30, 2025 10:30AM
Aug 1, 2025 02:00PM
Jul 28, 2025 01:00AM
Jul 24, 2025 09:00AM
Jul 18, 2025 11:45AM FDA rejects Genentech's Columvi combination for lymphoma treatment
Jul 18, 2025 11:45AM
Jun 20, 2025 11:48AM
Jun 20, 2025 11:45AM
Jun 16, 2025 11:30AM
Jun 2, 2025 04:05PM
May 31, 2025 08:05AM
May 30, 2025 01:00AM Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis
May 23, 2025 01:00AM
May 22, 2025 11:45AM
May 20, 2025 02:58PM
May 13, 2025 01:00AM
Apr 25, 2025 01:00AM
Apr 2, 2025 11:45AM
Apr 2, 2025 07:07AM Quest Diagnostics (DGX) Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
Apr 2, 2025 07:06AM

322,933 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All